SCHEMBL23913830

SCHEMBL23913830

c1ccc(-c2cccc3oc4cc(-c5nc(-c6cccc(-c7cccc8c7sc7ccccc78)c6)nc(-c6ccc7c(c6)oc6ccccc67)n5)ccc4c23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 8/20 0.46
ALOX5 P09917 2/20 0.46
LIMK1 P53667 2/20 0.36
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
F9 P00740 1/20 0.33
BACE1 P56817 1/20 0.33
HCRTR1 O43613 1/20 0.33
MAPT P10636 1/20 0.33
BRD4 O60885 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
KCNH2 Q12809 1/20 0.32
BRDT Q58F21 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23913223 0.97 PRKDC (0.45) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL21261182 0.97 PRKDC (0.47) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL23228112 0.96 PRKDC (0.48) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL25459328 0.95 PRKDC (0.46) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL25459331 0.95 PRKDC (0.47) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL23349784 0.94 PRKDC (0.46) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL23820953 0.94 PRKDC (0.46) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL21239158 0.94 PRKDC (0.49) PRKDCALOX5PIK3CDPIK3CBF9
SCHEMBL24216464 0.93 PRKDC (0.47) PRKDCALOX5LIMK1PIK3CDPIK3CB
SCHEMBL21261215 0.93 PRKDC (0.47) PRKDCALOX5LIMK1PIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 PRKDC 4327/4885ALOX5 1095/4885LIMK1 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.